HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Postoperative pain following epi-LASIK, LASEK, and PRK for myopia.

AbstractPURPOSE:
To compare mechanical epithelial separation using the epi-LASIK technique with alcohol assisted separation (LASEK).
METHODS:
Patients deemed suitable for surface ablation were randomized to receive epi-LASIK in one eye and LASEK in the other eye. If epi-LASIK failed, the procedure was converted to photorefractive keratectomy (PRK), forming the third comparison group. The outcome measures were postoperative pain, vision, refraction, and haze. Patients were followed for 3 months.
RESULTS:
Fifty-seven patients (95 eyes) were included in this study (38 epi-LASIK, 19 PRK, and 38 LASEK eyes). There was a 33% rate of conversion from intended epi-LASIK to PRK. Epi-LASIK patients were found to have significantly less pain in the first few hours after surgery but at 4 hours all patients had the same levels of pain, which improved to minimal or no pain at 24 hours. No significant difference was noted among groups for vision, refractive error, and haze; however, epi-LASIK patients had the best day 1 visual acuity.
CONCLUSIONS:
Epi-LASIK offers comparable visual and refractive results to other surface ablation techniques with lower levels of postoperative pain only for the first 2 hours. However, there was a high rate of flap failure and conversion to PRK.
AuthorsMaeve O'Doherty, Caitriona Kirwan, Michael O'Keeffe, John O'Doherty
JournalJournal of refractive surgery (Thorofare, N.J. : 1995) (J Refract Surg) Vol. 23 Issue 2 Pg. 133-8 (Feb 2007) ISSN: 1081-597X [Print] United States
PMID17326352 (Publication Type: Journal Article, Randomized Controlled Trial)
Topics
  • Adult
  • Follow-Up Studies
  • Humans
  • Keratectomy, Subepithelial, Laser-Assisted
  • Keratomileusis, Laser In Situ
  • Lasers, Excimer
  • Myopia (surgery)
  • Pain Measurement
  • Pain, Postoperative (diagnosis)
  • Photorefractive Keratectomy
  • Prospective Studies
  • Refraction, Ocular
  • Severity of Illness Index
  • Treatment Outcome
  • Visual Acuity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: